Table 2.
Intention to treat analysis of asthma control and self efficacy in people with asthma randomised to mobile phone or paper based monitoring
| No in group | Mean (SD) | Mean change (95% CI) | Mean difference of mean change (95% CI) | ||
|---|---|---|---|---|---|
| Baseline | 6 months | ||||
| Primary outcomes | |||||
| ACQ: | |||||
| Mobile | 139 | 2.32 (0.73) | 1.57 (0.99) | 0.75 (0.61 to 0.89) | −0.02 (−0.23 to 0.19) |
| Paper | 139 | 2.29 (0.77) | 1.56 (1.09) | 0.73 (0.57 to 0.89) | |
| KASE-AQ (self efficacy scale): | |||||
| Mobile | 110 | 77.4 (9.5) | 81.8 (11.1) | −4.4 (−6.1 to −2.7) | 2.0 (−0.3 to 4.2) |
| Paper | 121 | 78.0 (10.5) | 80.4 (11.5) | −2.4 (−3.9 to −0.9) | |
| KASE-AQ (attitude scale): | |||||
| Mobile | 118 | 80.0 (7.4) | 81.8 (9.5) | −1.7 (−2.9 to −0.6) | −0.2 (−1.6 to 1.6) |
| Paper | 122 | 79.4 (7.2) | 81.2 (8.6) | −1.8 (−2.9 to −0.6) | |
| Questionnaire based secondary outcomes | |||||
| mini-AQLQ: | |||||
| Mobile | 97 | 4.25 (0.91) | 5.0 (1.32) | −0.75 (−0.94 to −0.57) | 0.10 (−0.16 to 0.34) |
| Paper | 104 | 4.34 (1.08) | 4.99 (1.34) | −0.65 (−0.84 to −0.46) | |
| mPEI: | |||||
| Mobile | 136 | 5.83 (3.67) | 6.79 (4.0) | −0.96 (−1.62 to −0.31) | 1.19 (0.26 to 2.11) |
| Paper | 35 | 6.93 (3.78) | 6.71 (3.92) | 0.22 (−0.44 to 0.88) | |
ACQ=asthma control questionnaire; KASE-AQ=knowledge, attitude, and self efficacy asthma questionnaire; AQLQ=asthma quality of life questionnaire; mPEI=modified patient enablement instrument.